DeepCell
Where AI meets living cells
San Francisco Bay Area, United States · Founded 2017 · $20.0M raised
- Headquarters
- San Francisco Bay Area, California
- Employees
- 51–200
- Founded
- 2017
- Business Model
- B2B
- Website
- deepcell.com
- Total Funding
- $20.0M
- Last Round
- $20.0M Series ADec 2020
- Rounds
- 1
About
DeepCell is a life sciences technology company that has developed the REM-I platform — an integrated system combining label-free imaging, deep learning AI, and gentle cell enrichment to analyze and sort living cells based on their morphology. The platform enables researchers and clinicians to profile single cells without fluorescent labels or destructive preparation, revealing high-dimensional biological insights invisible to conventional methods. Key application areas include oncology (tumor heterogeneity, rare cell sorting), drug discovery (phenotypic screening, mechanism of action), and cell and gene therapy (quality control, manufacturing). DeepCell is headquartered in Menlo Park, California.
Summary
DeepCell is an Artificial Intelligence company based in San Francisco Bay Area, United States, founded in 2017. It has raised $20.0M in total across 1 round, most recently a $20.0M Series A round in Dec 2020. Investors include Bow Capital and Andreessen Horowitz.
Tech & App Stack
6 technologies & apps tracked
Create a free account — 25 credits a month to unlock the full tech & app stack, funding history, and valuations.
Sign up to view the funding chart
Create a free account — 25 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Dec 2020
Investors
Similar Companies
China's leading blood products manufacturer
Global contract research organization providing comprehensive drug development and laboratory ser...
Next-gen Medicare Advantage insurance plan with AI-forward medical group delivering quality and s...

Global fertility clinics platform

Specialty pharmaceutical company
Biopharmaceutical services company

